FILTER

Refine your search with the following facets to narrow down your results.

5 Current news of Medicines for Malaria Venture

Merck Serono and Medicines for Malaria Venture Sign Agreement to Develop Potential Antimalarial Therapy

08-Apr-2015 - Merck Serono, the biopharmaceutical business of Merck, and Medicines for Malaria Venture (MMV) announced that an agreement has been signed for Merck Serono to obtain the rights to the investigational antimalarial compound DDD107498 from MMV. This agreement underscores the commitment of Merck ...

drug development malaria Merck Serono

Evotec and Medicines For Malaria Venture announce a long-term compound management collaboration

20-Aug-2014 - Evotec AG announced the start of a multi-year compound management agreement between Evotec (US) Inc. and Medicines for Malaria Venture ("MMV") in support of MMV's Malaria and Pathogen Box initiatives. These two initiatives are expected to revolutionise the field of drug discovery for malaria and ...

drug discovery Evotec malaria

BioFocus DPI and Medicines for Malaria Venture collaborate to identify anti-malarial compounds

20-Apr-2009 - BioFocus DP and the not-for-profit organization Medicines for Malaria Venture (MMV) announced the start of a collaboration to identify new natural product and small molecules that demonstrate anti-malarial activity. Prior to the collaboration, MMV had acquired access to BioFocus DPI’s natural ...

BioFocus DPI malaria

Genzyme and Medicines for Malaria Venture Announce New Collaboration with Advinus Therapeutics for Novel MalariaTherapies

27-Aug-2008 - Genzyme Corp. and Medicines for Malaria Venture (MMV) announced a new collaboration with India’s Advinus Therapeutics Ltd. The collaboration seeks to develop new, improved treatments for specific patient groups most at risk for malaria. The ongoing MMV/Genzyme partnership also includes The Broad ...

drug resistance enzymes Genzyme +3

Medicines for Malaria Venture, Genzyme Corporation and the Broad Institute Expand Collaboration to Discover New Malaria Drugs

20-Oct-2006 - Medicines for Malaria Venture (MMV), Genzyme Corp., and the Broad Institute of MIT and Harvard announced that they have expanded their collaboration to discover and advance new therapeutic candidates for malaria. The alliance will build on work begun earlier this year and will enable the ...

Genzyme malaria scale-up